Research and Markets: Anthrax - Pipeline Review, H1 2013 Provides Coverage of the Anthrax Pipeline on the Basis of Route of Administration and Molecule Type

DUBLIN--()--Research and Markets (http://www.researchandmarkets.com/research/8w9l7s/anthrax) has announced the addition of the "Anthrax - Pipeline Review, H1 2013" report to their offering.

Global Markets Direct's, 'Anthrax - Pipeline Review, H1 2013', provides an overview of the indication's therapeutic pipeline. This report provides information on the therapeutic development for Anthrax, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Anthrax. Anthrax - Pipeline Review, Half Year is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team.

Scope

- A snapshot of the global therapeutic scenario for Anthrax.

- A review of the Anthrax products under development by companies and universities/research institutes based on information derived from company and industry-specific sources.

- Coverage of products based on various stages of development ranging from discovery till registration stages.

- A feature on pipeline projects on the basis of monotherapy and combined therapeutics.

- Key discontinued pipeline projects.

- Latest news and deals relating to the products.

Companies Mentioned:

  • Aradigm Corporation
  • Bavarian Nordic A/S
  • Cangene Corporation
  • Elusys Therapeutics, Inc.
  • Emergent BioSolutions Inc.
  • Evolva SA
  • Green Cross Corporation
  • iBio, Inc.
  • ImmunoVaccine Technologies Inc.
  • NanoBio Corporation
  • NasVax Ltd.
  • Oragenics, Inc.
  • Panacea Biotec Limited
  • PaxVax
  • Pfenex Inc.
  • Phage Biotechnology Corporation
  • PharmAthene, Inc.
  • PolyMedix, Inc.
  • Revivicor, Inc.
  • SelectX Pharmaceuticals, Inc.
  • Soligenix, Inc.
  • Summit Corporation plc
  • Tetraphase Pharmaceuticals Inc.
  • Vaxin, Inc.

For more information visit http://www.researchandmarkets.com/research/8w9l7s/anthrax

About Research and Markets

Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Contacts

Research and Markets
Laura Wood, Senior Manager.
press@researchandmarkets.com
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Infectious Diseases

Contacts

Research and Markets
Laura Wood, Senior Manager.
press@researchandmarkets.com
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Infectious Diseases